47 related articles for article (PubMed ID: 23067538)
1. 18F-Misonidazole PET-CT scan detection of occult bone metastasis.
McGowan DR; Macpherson RE; Bradley KM; Fenwick JD; Gleeson FV; Higgins GS
Thorax; 2016 Jan; 71(1):97. PubMed ID: 26349764
[No Abstract] [Full Text] [Related]
2. Recurrent Metastatic Ewing Sarcoma Involving Only in the Muscles of Extremities Shown on FDG PET/CT.
Fleury AS; Zhuang H
Clin Nucl Med; 2024 Jun; 49(6):589-591. PubMed ID: 38537215
[TBL] [Abstract][Full Text] [Related]
3. PET/CT in oncology.
Fahim-Ul-Hassan ; Cook GJ
Clin Med (Lond); 2012 Aug; 12(4):368-72. PubMed ID: 22930885
[No Abstract] [Full Text] [Related]
4. [Management of bone metastasis in non-small cell lung cancer].
Apeiranthiti A; Vanniere F; Bayoumy K; Christofis M; Serena A; Mosimann V; Abdelhamid K; Papadopoulos S; Nguyen-Ngoc T; Bouchaab H; Peters S; Mederos N
Rev Med Suisse; 2024 May; 20(874):973-977. PubMed ID: 38756034
[TBL] [Abstract][Full Text] [Related]
5. Functional imaging biomarkers for assessing response to treatment in liver and lung metastases.
Bernardin L; O'Flynn EA; Desouza NM
Cancer Imaging; 2013 Dec; 13(4):482-94. PubMed ID: 24334562
[TBL] [Abstract][Full Text] [Related]
6. Clinical Features, Treatments, and Prognosis of Intramedullary Spinal Cord Metastases From Lung Cancer: A Case Series and Systematic Review.
Wu L; Wang L; Yang J; Jia W; Xu Y
Neurospine; 2022 Mar; 19(1):65-76. PubMed ID: 35130420
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of non-osseous spinal metastatic disease: the role of PET/CT and PET/MRI.
Batouli A; Braun J; Singh K; Gholamrezanezhad A; Casagranda BU; Alavi A
J Neurooncol; 2018 Jun; 138(2):221-230. PubMed ID: 29484521
[TBL] [Abstract][Full Text] [Related]
8. Positron Emission Tomography (PET) radiotracers in oncology--utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC).
Miele E; Spinelli GP; Tomao F; Zullo A; De Marinis F; Pasciuti G; Rossi L; Zoratto F; Tomao S
J Exp Clin Cancer Res; 2008 Oct; 27(1):52. PubMed ID: 18928537
[TBL] [Abstract][Full Text] [Related]
9. Intramedullary metastasis detected with 18F FDG-PET/CT.
Sari O; Kaya B; Kara Gedik G; Ozcan Kara P; Varoglu E
Rev Esp Med Nucl Imagen Mol; 2012 Sep; 31(5):299-300. PubMed ID: 23067538
[No Abstract] [Full Text] [Related]
10. Multiple distant muscular metastases from non-small cell lung carcinoma evidenced by 18F-FDG PET/CT.
Caobelli F; Pizzocaro C; Guerra UP
Rev Esp Med Nucl Imagen Mol; 2013; 32(5):338-9. PubMed ID: 23809515
[No Abstract] [Full Text] [Related]
11. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
Wu Y; Li P; Zhang H; Shi Y; Wu H; Zhang J; Qian Y; Li C; Yang J
Int J Cancer; 2013 Jan; 132(2):E37-47. PubMed ID: 22890912
[TBL] [Abstract][Full Text] [Related]
12. Intramedullary spinal cord metastasis.
Pellegrini D; Quezel MA; Bruetman JE
Arch Neurol; 2009 Nov; 66(11):1422. PubMed ID: 19901180
[No Abstract] [Full Text] [Related]
13. [Value of 18F-FDG PET in clinical staging of non-small-cell lung cancer].
Liu SW; Yu JM; Xing LG
Zhonghua Zhong Liu Za Zhi; 2004 Oct; 26(10):626-9. PubMed ID: 15634527
[TBL] [Abstract][Full Text] [Related]
14. Intramuscular metastases on FDG PET-CT: a review of the literature.
Emmering J; Vogel WV; Stokkel MP
Nucl Med Commun; 2012 Feb; 33(2):117-20. PubMed ID: 22124361
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]